Organization and Nature of Business (Details) |
3 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2022
USD ($)
segment
|
Mar. 31, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
|
|
| Subsidiary, Sale of Stock [Line Items] | |||
| Number of operating segments | segment | 1 | ||
| Net loss | $ 3,960,308 | $ 3,056,033 | |
| Net cash used in operating activities | 2,656,017 | $ 5,112,202 | |
| Accumulated deficit | $ 47,885,681 | $ 43,925,373 | |
| Minimum | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| period in which the company has to raise additional capital to complete clinical development | 9 months | ||
| Maximum | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| period in which the company has to raise additional capital to complete clinical development | 12 months | ||
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The period in which the company has to raise additional capital to complete clinical development. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|